ストックスクリーナーアプリを入手
5.93
1.82%
-0.11
前日終値:
$6.04
開ける：
$6.07
24時間の取引高:
48,413
Relative Volume:
0.05
時価総額：
$88.85M
収益：
$41.94M
当期純損益:
$-7.40M
株価収益率:
-12.02
EPS:
-0.4935
ネットキャッシュフロー:
$1.29M
1週間 パフォーマンス:
-6.91%
1か月 パフォーマンス:
+8.21%
6か月 パフォーマンス:
+19.80%
1年 パフォーマンス:
+77.54%
1日の値動き範囲:
$5.76
$6.1451
1週間の範囲:
$5.76
$6.75
52週間の値動き範囲:
$1.85
$7.355
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
名前
Cumberland Pharmaceuticals Inc
セクター
電話
615-255-0068
住所
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
5.93 | 88.85M | 41.94M | -7.40M | 1.29M | -0.4935 |
TAK
Takeda Pharmaceutical Co Adr
|
16.56 | 52.88B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.76 | 42.98B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.95 | 38.37B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.56 | 31.68B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
547.06 | 23.22B | 3.17B | 1.29B | 1.01B | 27.09 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2012-11-12 | 繰り返されました | UBS | Neutral |
| 2011-02-01 | 繰り返されました | UBS | Neutral |
| 2010-12-16 | ダウングレード | UBS | Buy → Neutral |
| 2010-08-17 | ダウングレード | Jefferies | Buy → Hold |
| 2010-08-17 | 繰り返されました | Morgan Joseph | Buy |
| 2010-08-17 | 繰り返されました | UBS | Buy |
| 2010-05-14 | 繰り返されました | Morgan Joseph | Buy |
すべてを表示
Cumberland Pharmaceuticals Inc (CPIX) 最新ニュース
Cumberland outlines new product expansion and sees $8.3M Q3 revenues while advancing clinical pipeline - MSN
Cumberland Pharmaceuticals Sells Branded Drug Portfolio to Apotex for $100M, Refocuses on Rare Disease Pipeline 1 - Minichart
CPIXCumberland Pharmaceuticals Inc Latest SEC Filings - Finviz
Cumberland Refocuses on Rare Disease Pipeline After Asset Sale - TipRanks
Cumberland (CPIX) nets $100M from Apotex deal, shifts to rare disease pipeline - Stock Titan
Cumberland Pharmaceuticals closes $100 million sale of drug portfolio - The Business Journals
Cumberland sells branded drug portfolio to Apotex for $100m By Investing.com - Investing.com South Africa
Cumberland sells branded drug portfolio to Apotex for $100m - Investing.com
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - The Globe and Mail
Cumberland sells branded U.S. drugs to Apotex for $100M - Stock Titan
Cumberland Pharma advances Duchenne program with new safety, efficacy data - MSN
Cumberland Pharma Advances Duchenne Program With New Safety, Efficacy Data - Sahm
Cumberland shares updated trial results for DMD heart therapy - Investing.com UK
Why Is Cumberland Pharma Stock Gaining Friday?Cumberland Pharma (NASDAQ:CPIX) - Benzinga
Cumberland says updated DMD heart data strengthen ifetroban case - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Shareholders back Cumberland (NASDAQ: CPIX) sale of most assets - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Institutional Confidence - TradingKey
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement - Sahm
RedHill closes $6M financing, with up to $13.4M more possible - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RedHill Biopharma raises $6M now, with $13.4M more tied to warrants - Stock Titan
Cumberland Pharmaceuticals Inc - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CPIX News | CUMBERLAND PHARMACEUTICALS (NASDAQ:CPIX) - ChartMill
CPIX Q1 2026 Earnings: Narrowing Losses Amidst Operational UncertaintyEPS Surprise History - newsline.com
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Martin S JR - Moomoo
Cumberland Pharmaceuticals (CPIX) Slips 0.79% as Stock Hovers Near Key Support LevelFundamentals - dars.gov.et
RedHill moves to enforce $10.9M New York judgment on Kukbo in Korea - Stock Titan
Cumberland Pharmaceuticals (CPIX) Extends Decline Amid Low Volume PressurePrice Target - newsline.com
Cumberland shares soar on $100M deal announcement - Nashville Post
Cumberland reports positive phase 2a cancer trial results - Investing.com UK
Cumberland reports positive phase 2a cancer trial results By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals And Vanderbilt Announce Phase 2A Trial Data For ifetroban In High-Risk Solid Tumors - TradingView
Early trial hints at drug to cut risk of cancer returning after treatment - Stock Titan
Pilot Study Demonstrates Safety of Ifetroban for Patients With High-Risk Solid Tumors, Suggests Potential to Block Cancer Metastasis | Newswise - Newswise
Cumberland Pharmaceuticals (CPIX) Rises 2.84%: Support Holds as Stock Approaches ResistanceTrend Following Picks - dars.gov.et
Cumberland Pharmaceuticals (CPIX) Gains Momentum: Up 2.84% on Normal Trading ActivityIV Percentile - The Legal Advocate
Cumberland Pharma Stock Rises After China Antibiotic Launch — Why Investors Are Watching - Bez Kabli
Cumberland Pharmaceuticals Hits New 52-Week High of $6.51 - MarketsMojo
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA - Citizen Tribune
Number of shareholders of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial - Yahoo Finance
New MRSA-fighting antibiotic Vibativ now available to patients in China - Stock Titan
CPIX Q1 2026 Earnings: Net Loss Reported, Shares Edge HigherGuidance Revision Trend - The Legal Advocate
CPIX Q1 2026 Earnings: Narrowing Losses and Strategic Progress Amidst Revenue ChallengesDividend Increase Stocks - The Legal Advocate
Cumberland Pharmaceuticals(CPIX) Stock Options Chain | Quotes & News - Moomoo
Cumberland Pharmaceuticals Inc (CPIX) 財務データ
収益
当期純利益
現金流量
EPS
3.42%
0.81%
大文字化:
|
ボリューム (24 時間):